I could give my perspective on that.
The way Bill C-11 addresses level 2 pathogens in this bill in Canada is not what happens in the United States. They do not have those kinds of restrictions in the United States on level 2 pathogens. They do on levels 3 and 4. This bill is right on level 3 and 4, but it's not right on level 2.
In the United States there is a much freer exchange of reagents without having to get a federal permit first. There is not the security. I can walk into any laboratory in the United States and speak with a scientist there. They cannot do that to me. If a scientist comes from the United States to my lab, they can't come into my lab. So there is a difference. And it's the same thing in the U.K. and it's the same thing in Europe as well.